Category: Parry
-
Cannabis extractor Pure Extracts (PULL.C) stakes claim in the rocketing mushroom space
Barely a few weeks after telling the Equity.Guru audience that the timeline on mushrooms would see Pure Extracts (PULL.C) focusing on its core cannabis market, evolving market dynamics and a renewed focus on the potential of psychedelics have seen the company hit the gas on its long term shroom plans. With interest in functional and…
-
FansUnite (FANS.C) flying hard, a three-week three-bagger as revenues leap
FansUnite (FANS.C) is the star of the junior exchanges these past few weeks, accelerating hard on the back of good financial news earlier this month, to be up some 200% in three weeks. The run has seen stock in the company move from a 52-week low of $0.185 up to $0.57 today, with trading volume…
-
Delic Holdings (DELC.C) emerges as a psychedelics play aimed at executing real, legal business, and right now
Smallcap investors largely see the psychedelics space in one of two ways; you’re either in the ‘this may be big one day but there’s not a lot of fat on the bones just yet so I’ll wait’ camp, or the ‘fat schmat, everything is a trade and who cares about tomorrow’ camp. I’m pegged pretty…
-
Pure Extracts (PULL.C) goes public with profit-focused cannabis (and mushroom) extraction business model
Yeah, I know, I know. Canadian cannabis companies are ass right now, and have been for a few years. Trust me, I’m about as out of the LP business now as I’ve ever been, but you’d also be an idiot to tar every cannabis company with the same brush, because not every deal involves growing…
-
Brigadier Gold (BRG.V) sees rich veins extending in early results of new drilling program
If you’ve ever watched the litany of gold mining programs on cable TV’s reality TV channels, you’ve seen folks jumping up and down like they have a weasel in their pants whenever they hit enough gold to cast a teenager’s valentine pendant. “OMG IT’S A BEAUTY!” will cry some rough around the edges Australian with…
-
Revive Therapeutics (RVV.C) to have 10 clinical COVID-19 FDA trial sites by end of year
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks laughed uproariously at the thought that a three time loser might be relevant in 2020. Having missed on an earlier pharma focus, and come to the cannabis party a little…
-
Perimeter Medical Imaging AI (PINK.V) isn’t messing about: Let’s make breast cancer treatment better – and profitable!
In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to trial’, and a lot of ‘billion dollar industry’ talk. Lots of early stage bets, a little over-hype perhaps. For the most part, you’re being asked to invest in technologies that…
-
Aequus Pharmaceuticals (AQS.V) gets Health Canada device licence approval, validates business model
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced another win Monday morning with news Health Canada has approved the advancing of their Evolve dry-eye relief gel line to an easy-squeeze eye drop bottle. Admittedly,…
-
![FansUnite (FANS.C) agrees e-sports data supply deal with online betting platform]()
FansUnite (FANS.C) agrees e-sports data supply deal with online betting platform
Just a few months since announcing they were merging with Askott Entertainment, a deal that brought casino gaming and daily fantasy sports access to FansUnite’s (FANS.C) sports betting platform, FANS has announced another partnership, this time with Pinnacle Solutions, an award-winning online B2B e-sports betting platform. The deal will add Pinnacle’s e-sports data and odds…
-
Watch me: I can sell you on CLS Holdings (CLSH.C), with its one dispensary, being a better buy than Trulieve (TRUL.C), with 52
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for the cannabis crowd, and a rough last year for everyone else. With Aurora Cannabis (ACB.T) losing the gross national product of Panama, Chuck Rifici bailing from…
